UPDATE 1-Agenus brain cancer vaccine doubles survival rate in study
July 01, 2014 at 08:17 AM EDT
July 1 (Reuters) - Agenus Inc said its experimental cancer vaccine helped brain tumor patients live nearly twice as long compared with those who received standard of care treatment.